Abstract # 2512 Acute Esophageal Reactions from Proton Beam Therapy and Concurrent Chemotherapy for Non-Small Cell Lung Cancer (NSCLC): Reduction in Incidence and Severity Despite Higher Doses

Presenter: Cox, James

< Back to topics

> Cover Page, Authors, Institutions

> Purpose/Objective

> Materials/Methods

> Results/Discussion

> Conclusions

> View tables/images/videos

About the Presenter:
Dr. James D. Cox is Professor of Radiation Oncology and Head of the Division of Radiation Oncology at M. D. Anderson Cancer Center, where he holds the Hubert L. and Olive Stringer Distinguished Chair in Oncology. Since joining the M. D. Anderson faculty in 1988, he has served in such highly visible positions as vice president for patient care, physician-in-chief and director of Interdisciplinary Program Development. An outstanding radiation oncologist and a productive researcher, he is widely known and held in highest regard for ongoing leadership in designing, implementing and analyzing clinical trials that have led to more effective therapies. He has served on NCIs Clinical Trials Review Committee and on the Task Force on Clinical Trials of the National Cancer Advisory Board and has chaired the NCIs Committee of Clinical Trials Cooperative Group Chairs. He has also served as president and then chairman of the Board of Trustees of the American Society for Therapeutic Radiology and Oncology (ASTRO) and represented ASTRO in the American College of Radiology. He has also been a member of NCIs Board of Scientific Counselors for the Division of Cancer Treatment. He is a past president of both the American Society for Therapeutic Radiology and Oncology and the Society of Chairmen of Academic Oncology Programs. Moreover, he has been active in the International Society for the Study of Lung Cancer and the International Congress of Radiation Oncology. In 1999, he became chair of the Scientific Program Committee of the American Radium Society and in 2003 served as its President. Dr. Cox is also the author of 400 scientific publications. Under Dr. Coxs leadership, the Division of Radiation Oncology has garnered international acclaim for the facultys landmark contributions to patient care, clinical research, translational radiobiology and radiation physics. With more than 400 patients a day receiving radiation therapy at M. D. Anderson, our radiation oncologists offer an accumulated experience that is unmatched at any other cancer center.
Contact the presenter at: jcox@mdanderson.org

Authors:
J. D. Cox*1, J. Y. Chang*2, Z. Liao*2, M. K. Bucci*2, M. F. McAleer*2, X. Wei*3, P. K. Allen*2, H. Cai*2, M. Gillin*2, X. R. Zhu*2. , et al., 1UT M.D. Anderson Cancer Center, Houston, TX, 2UT M. D. Anderson Cancer Center, Houston, TX, 3UT M. D. Anderson C

Author Disclosure:
J.D. Cox, Pro Beam, F. Consultant/Advisory Board;J.Y. Chang, None;Z. Liao, None;M.K. Bucci, None;M.F. McAleer, None;X. Wei, None;P.K. Allen, None;H. Cai, None;M. Gillin, None;X.R. Zhu, None.


E-mail a friend about this abstract:
Enter email address: